NCT05880550

Brief Summary

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Women with this syndrome may have infrequent menstrual periods or amenorrhea and excess androgen levels. The ovaries develop numerous small follicles and fail to ovulate on a regular basis, with subsequent subfertility in those women that wish to conceive. Recent research stated that interventions aiming to improve QoL among infertile women with PCOS should focus on alleviating infertility-related stress, especially among women with high BMI. So, the purpose of this study is to investigate the effect of ultrasound cavitation combined with aerobic exercise on menstrual irregularity and infertility related stress in women having PCOS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2023

Completed
6 days until next milestone

Study Start

First participant enrolled

May 25, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 30, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 25, 2023

Completed
Last Updated

May 14, 2024

Status Verified

May 1, 2024

Enrollment Period

3 months

First QC Date

May 19, 2023

Last Update Submit

May 11, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Infertily related Stress level

    Infertility-Related Stress Scale is a concise, reliable, and validated tool; it facilitates quick screening for infertility's impact on intrapersonal and interpersonal life domains. The IRSS consists of 12 items rated from 1 ("no stress") to 7 ("high stress")., with higher grades means higher stress.

    change from base line at 12 weeks.

  • cortisol level

    Saliva samples will be collected with study participants sitting upright in a comfortable position and tilting the head forward, allowing the saliva to pool on the floor of the mouth

    change from base line at 12 weeks.

Secondary Outcomes (2)

  • Anthrometric measurement (body mass index and waist-hip ratio)

    change from base line at 12 weeks.

  • Hormonal profile

    change from base line at 12 weeks.

Study Arms (2)

study group

EXPERIMENTAL
Other: ultrasound cavitation in addition to aerobic ex

control group

ACTIVE COMPARATOR
Other: aerobic exercises.

Interventions

Ultrasonic cavitation was turned on, the program of cavitation 40 kHz was chosen, the time was adjusted at 30 minutes. The cavitational head was moved very slowly on each abdominal segment in a small circular movement for 5 minutes. After finishing the focused ultrasound of the 6 segments of the abdomen, the skin was cleaned with cotton. in addition to that the patients will receive aerobic exercises for 40 minutes.

study group

the patients will do aerobic training for 40 minutes on a bicycle ergometer.

control group

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All women in this study will be on the following criteria:
  • Their ages will range from 20-35 years.
  • They will be diagnosed with PCOS by Gynecologist.
  • Doesn't receive any treatment for menstrual regularity and fertility during the study.
  • BMI above 25kg/m²and less than 35kg/m².
  • Waist /hip ratio \<.88.

You may not qualify if:

  • Women will be excluded if they have one of the following criteria:
  • Skin diseases that prevent the application of cavitation.
  • Severe cardiovascular disease.
  • Other endocrine disordered (hypothyroidism hyperprolactinemia).
  • Patients that who take hormonal treatment within the last 3 months before the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marwa Shafiek Saleh

Giza, 12613, Egypt

Location

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Interventions

Exercise

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistance professor doctor

Study Record Dates

First Submitted

May 19, 2023

First Posted

May 30, 2023

Study Start

May 25, 2023

Primary Completion

August 25, 2023

Study Completion

September 25, 2023

Last Updated

May 14, 2024

Record last verified: 2024-05

Locations